BRIEF published on 02/19/2025 at 19:15, 1 year ago Aspire Biopharma Begins Trading on Nasdaq Following Merger Nasdaq Listing Business Combination Public Offering Drug Delivery Technology Aspire Biopharma
BRIEF published on 02/19/2025 at 19:15, 1 year ago Aspire Biopharma commence à être cotée au Nasdaq après sa fusion Technologie D'administration De Médicaments Cotation Au Nasdaq Regroupement D’entreprises Offre Publique De Vente Aspire Biopharma
PRESS RELEASE published on 02/19/2025 at 19:10, 1 year ago Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq Aspire Biopharma and PowerUp Acquisition Corp. completed their business combination, enhancing access to capital and new product development. Shares to trade on Nasdaq as ASBP and ASBPW Nasdaq Business Combination Aspire Biopharma PowerUp Acquisition Corp. Drug Delivery Mechanism
Published on 02/20/2026 at 21:40, 32 minutes ago IBC Advanced Alloys Announces Closing of Initial US$1,250,000 Funding by The Lind Partners
Published on 02/20/2026 at 20:15, 1 hour 57 minutes ago Lithium South Announces Results of its Annual and Special Meeting of Securityholders
Published on 02/20/2026 at 20:15, 1 hour 57 minutes ago Verdera Energy Announces Closing of Qualifying Transaction
Published on 02/20/2026 at 18:30, 3 hours 42 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 6 hours 27 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 18:36, 3 hours 36 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 3 hours 41 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 4 hours 12 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 4 hours 12 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 19:29, 2 hours 43 minutes ago SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 2 hours 43 minutes ago SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 4 hours 12 minutes ago TERACT - Résiliation du contrat de liquidité